Improving clinical trial accrual by streamlining the referral process

被引:5
作者
Afrin, Lawrence B. [1 ]
Oates, James C. [2 ]
Kamen, Diane L. [2 ]
机构
[1] Univ Minnesota, Div Hematol Oncol & Transplantat, Minneapolis, MN 55455 USA
[2] Med Univ S Carolina, Div Rheumatol, Charleston, SC 29425 USA
关键词
Clinical trials; Clinical trial accrual; Clinical trial information systems; Clinical research workflow; DRUG DEVELOPMENT COSTS; CANCER-PATIENTS; BREAST-CANCER; BARRIERS; PARTICIPATION; CARE; ATTITUDES; ONCOLOGY; COMPLEXITY; INNOVATION;
D O I
10.1016/j.ijmedinf.2014.09.001
中图分类号
TP [自动化技术、计算机技术];
学科分类号
0812 ;
摘要
Objective: Poor accrual rates impede clinical trial efficiency and significantly contribute to development costs for new interventions. Many providers recognize investigational treatments are their patients' best opportunities for improvement, but operational clinical burdens impede providers' awareness of, and ability to leverage, such opportunities. We aimed to develop a new workflow for non-intrusively apprising providers of trial opportunities for their patients and enabling providers to efficiently refer potential trial candidates to study teams for preliminary eligibility review. Materials and methods: We developed a small information system to monitor institutional systems, identify patients potentially eligible for ongoing clinical trials, and give providers a non-intrusive, one-click method to refer such patients to study teams for preliminary eligibility vetting. Results: In 18 months of pilot experience, providers invited study teams to vet 11% of 1844 patients found potentially eligible for 38 trials registered with the system. Seventy-nine patients were conservatively estimated to be accrued. Accrual rates were boosted for several trials. Results of a survey indicated most users were satisfied with the system. Discussion: Providers' time constraints impede their pursuit of investigational opportunities for their patients. In pilot experience, our novel approach to facilitating such pursuits yielded improved accrual, benefiting trials and presumably patients, too. Our approach may bear particular fruit for cross-disciplinary referrals for screening. Conclusion: Systems for assisting providers in making investigational opportunities available to their patients may benefit from careful attention to provider workflow and time constraints. Our system might further benefit from improved patient/trial matching and shorter messages. (C) 2014 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:15 / 23
页数:9
相关论文
共 37 条
  • [1] Estimating the cost of new drug development: Is it really $802 million?
    Adams, CP
    Brantner, VV
    [J]. HEALTH AFFAIRS, 2006, 25 (02) : 420 - 428
  • [2] Afrin Lawrence B, 2003, AMIA Annu Symp Proc, P16
  • [3] Recruitment and participation in clinical trials: Socio-demographic, rural/urban, and health care access predictors
    Baquet, CR
    Commiskey, P
    Mullins, CD
    Mishra, SI
    [J]. CANCER DETECTION AND PREVENTION, 2006, 30 (01): : 24 - 33
  • [4] Public attitudes toward participation in cancer clinical trials
    Comis, RL
    Miller, JD
    Aldigé, CR
    Krebs, L
    Stoval, E
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (05) : 830 - 835
  • [5] What can natural language processing do for clinical decision support?
    Demner-Fushman, Dina
    Chapman, Wendy W.
    McDonald, Clement J.
    [J]. JOURNAL OF BIOMEDICAL INFORMATICS, 2009, 42 (05) : 760 - 772
  • [6] Frequent overcrowding in US emergency departments
    Derlet, RW
    Richards, JR
    Kravitz, RL
    [J]. ACADEMIC EMERGENCY MEDICINE, 2001, 8 (02) : 151 - 155
  • [7] The price of innovation: new estimates of drug development costs
    DiMasi, JA
    Hansen, RW
    Grabowski, HG
    [J]. JOURNAL OF HEALTH ECONOMICS, 2003, 22 (02) : 151 - 185
  • [8] Physician Burnout A Potential Threat to Successful Health Care Reform
    Dyrbye, Liselotte N.
    Shanafelt, Tait D.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2011, 305 (19): : 2009 - 2010
  • [9] Attitudes towards and participation in randomised clinical trials in oncology: A review of the literature
    Ellis, PM
    [J]. ANNALS OF ONCOLOGY, 2000, 11 (08) : 939 - 945
  • [10] Embi Peter J, 2005, AMIA Annu Symp Proc, P231